Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Alexis

Showing results (71-80 of 82) with videos related to

Pageof 9
Sort By:
Journal of Cardiac Failure|April 15, 2024
Association of Psychosocial Risk Factors With Quality of Life and Readmissions 1 Year After LVAD ImplantationJeffrey Wang, Alexis K Okoh, Yuxuan Chen, et al.
Journal of Cardiac Failure|May 28, 2021
Enhanced Recovery After Surgery in Patients Implanted with Left Ventricular Assist DeviceDanielle M Lindenmuth, Karin Chase, Christina Cheyne, et al.
Circulation|May 3, 2018
Mechanosensitive Gene Regulation by Myocardin-Related Transcription Factors Is Required for Cardiomyocyte Integrity in Load-Induced Ventricular HypertrophyMichael A Trembley, Pearl Quijada, Esperanza Agullo-Pascual, et al.
JACC. Heart Failure|November 19, 2025
Hemocompatibility Outcomes With Pharmacological Therapy Following LVAD Implantation: Insights From the ARIES-HM3 TrialJason N Katz, Jean M Connors, Francis D Pagani, et al.
Journal of the American College of Cardiology|August 22, 2015
Clinical Outcomes for Peripartum Cardiomyopathy in North America: Results of the IPAC Study (Investigations of Pregnancy-Associated Cardiomyopathy)Dennis M McNamara, Uri Elkayam, Rami Alharethi, et al.
JAMA Cardiology|January 8, 2025
Aspirin and Hemocompatibility After LVAD Implantation in Patients With Atherosclerotic Vascular Disease: A Secondary Analysis From the ARIES-HM3 Randomized Clinical TrialFinn Gustafsson, Nir Uriel, Ivan Netuka, et al.
Heart Rhythm|February 7, 2025
Reassessing the need for primary prevention implantable cardioverter-defibrillators in contemporary patients with heart failureIlan Goldenberg, Justin Ezekowitz, Christine Albert, et al.
Journal of Cardiac Failure|February 6, 2025
Reassessing the need for primary prevention implantable cardioverter-defibrillators in contemporary patients with heart failureIlan Goldenberg, Justin Ezekowitz, Christine Albert, et al.
Journal of the American College of Cardiology|August 4, 2018
Ranolazine in High-Risk Patients With Implanted Cardioverter-Defibrillators: The RAID TrialWojciech Zareba, James P Daubert, Christopher A Beck, et al.
American Heart Journal|September 6, 2025
Rationale and Design of the Comparative Effectiveness of ICD Versus Non-ICD Therapy in Contemporary Heart Failure Patients at a Low Risk for Arrhythmic Death (CONTEMP-ICD) trialIlan Goldenberg, Wojciech Zareba, Justin A Ezekowitz, et al.
Pageof 9

Showing results (71-80 of 82) with videos related to

Sort By:
Pageof 9
Journal of Cardiac Failure|April 15, 2024
Association of Psychosocial Risk Factors With Quality of Life and Readmissions 1 Year After LVAD ImplantationJeffrey Wang, Alexis K Okoh, Yuxuan Chen, et al.
Journal of Cardiac Failure|May 28, 2021
Enhanced Recovery After Surgery in Patients Implanted with Left Ventricular Assist DeviceDanielle M Lindenmuth, Karin Chase, Christina Cheyne, et al.
Circulation|May 3, 2018
Mechanosensitive Gene Regulation by Myocardin-Related Transcription Factors Is Required for Cardiomyocyte Integrity in Load-Induced Ventricular HypertrophyMichael A Trembley, Pearl Quijada, Esperanza Agullo-Pascual, et al.
JACC. Heart Failure|November 19, 2025
Hemocompatibility Outcomes With Pharmacological Therapy Following LVAD Implantation: Insights From the ARIES-HM3 TrialJason N Katz, Jean M Connors, Francis D Pagani, et al.
Journal of the American College of Cardiology|August 22, 2015
Clinical Outcomes for Peripartum Cardiomyopathy in North America: Results of the IPAC Study (Investigations of Pregnancy-Associated Cardiomyopathy)Dennis M McNamara, Uri Elkayam, Rami Alharethi, et al.
JAMA Cardiology|January 8, 2025
Aspirin and Hemocompatibility After LVAD Implantation in Patients With Atherosclerotic Vascular Disease: A Secondary Analysis From the ARIES-HM3 Randomized Clinical TrialFinn Gustafsson, Nir Uriel, Ivan Netuka, et al.
Heart Rhythm|February 7, 2025
Reassessing the need for primary prevention implantable cardioverter-defibrillators in contemporary patients with heart failureIlan Goldenberg, Justin Ezekowitz, Christine Albert, et al.
Journal of Cardiac Failure|February 6, 2025
Reassessing the need for primary prevention implantable cardioverter-defibrillators in contemporary patients with heart failureIlan Goldenberg, Justin Ezekowitz, Christine Albert, et al.
Journal of the American College of Cardiology|August 4, 2018
Ranolazine in High-Risk Patients With Implanted Cardioverter-Defibrillators: The RAID TrialWojciech Zareba, James P Daubert, Christopher A Beck, et al.
American Heart Journal|September 6, 2025
Rationale and Design of the Comparative Effectiveness of ICD Versus Non-ICD Therapy in Contemporary Heart Failure Patients at a Low Risk for Arrhythmic Death (CONTEMP-ICD) trialIlan Goldenberg, Wojciech Zareba, Justin A Ezekowitz, et al.
Pageof 9